DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) – Research analysts at Zacks Research decreased their Q4 2024 earnings per share (EPS) estimates for DENTSPLY SIRONA in a research report issued on Thursday, November 28th. Zacks Research analyst I. Bandyopadhyay now anticipates that the medical instruments supplier will earn $0.45 per share for the quarter, down from their prior forecast of $0.58. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.84 per share. Zacks Research also issued estimates for DENTSPLY SIRONA’s Q1 2025 earnings at $0.42 EPS, Q2 2025 earnings at $0.51 EPS, Q3 2025 earnings at $0.50 EPS, Q4 2025 earnings at $0.54 EPS, FY2025 earnings at $1.97 EPS, Q1 2026 earnings at $0.48 EPS, Q2 2026 earnings at $0.55 EPS and Q3 2026 earnings at $0.53 EPS.
Other equities analysts have also recently issued reports about the stock. Leerink Partners cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Needham & Company LLC lowered their price objective on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a research report on Friday, October 25th. Robert W. Baird reduced their target price on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a report on Friday, November 8th. StockNews.com lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. Finally, Evercore ISI dropped their price objective on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. Seven investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of “Hold” and an average price target of $29.50.
DENTSPLY SIRONA Trading Up 0.9 %
XRAY opened at $19.82 on Monday. The stock has a market capitalization of $3.94 billion, a price-to-earnings ratio of -9.57, a P/E/G ratio of 1.93 and a beta of 0.97. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA has a twelve month low of $17.21 and a twelve month high of $37.60. The company has a 50-day simple moving average of $22.43 and a 200 day simple moving average of $24.68.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last released its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. During the same period in the prior year, the company posted $0.49 EPS. The company’s revenue was up .4% compared to the same quarter last year.
Institutional Investors Weigh In On DENTSPLY SIRONA
Hedge funds have recently modified their holdings of the company. Tidal Investments LLC boosted its stake in shares of DENTSPLY SIRONA by 292.4% during the first quarter. Tidal Investments LLC now owns 24,149 shares of the medical instruments supplier’s stock valued at $802,000 after purchasing an additional 17,995 shares in the last quarter. Comerica Bank boosted its position in DENTSPLY SIRONA by 2.9% during the 1st quarter. Comerica Bank now owns 42,568 shares of the medical instruments supplier’s stock worth $1,413,000 after buying an additional 1,205 shares during the period. Cetera Advisors LLC grew its holdings in DENTSPLY SIRONA by 18.6% during the 1st quarter. Cetera Advisors LLC now owns 17,052 shares of the medical instruments supplier’s stock worth $566,000 after acquiring an additional 2,675 shares during the last quarter. Teachers Retirement System of The State of Kentucky increased its position in DENTSPLY SIRONA by 6.2% in the 1st quarter. Teachers Retirement System of The State of Kentucky now owns 19,370 shares of the medical instruments supplier’s stock valued at $642,000 after acquiring an additional 1,130 shares during the period. Finally, OLD National Bancorp IN raised its stake in shares of DENTSPLY SIRONA by 84.2% during the second quarter. OLD National Bancorp IN now owns 13,560 shares of the medical instruments supplier’s stock valued at $338,000 after acquiring an additional 6,198 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Featured Articles
- Five stocks we like better than DENTSPLY SIRONA
- Why is the Ex-Dividend Date Significant to Investors?
- How to Master Trading Discipline: Overcome Emotional Challenges
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Trump Tax Reforms: 7 Stocks That Could Benefit in 2025
- Roth IRA Calculator: Calculate Your Potential Returns
- 3 Stocks Near 52-Week Lows: Why They Could Be Smart Buys Today
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.